Free Trial
NASDAQ:TENX

Tenax Therapeutics (TENX) Stock Price, News & Analysis

Tenax Therapeutics logo
$5.92 -0.07 (-1.09%)
As of 11:49 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Tenax Therapeutics Stock (NASDAQ:TENX)

Key Stats

Today's Range
$5.88
$6.00
50-Day Range
$5.62
$6.25
52-Week Range
$3.25
$7.89
Volume
3,347 shs
Average Volume
29,314 shs
Market Capitalization
$24.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.50
Consensus Rating
Buy

Company Overview

Tenax Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

TENX MarketRank™: 

Tenax Therapeutics scored higher than 26% of companies evaluated by MarketBeat, and ranked 817th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tenax Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tenax Therapeutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Tenax Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Tenax Therapeutics are expected to decrease in the coming year, from ($0.88) to ($3.30) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tenax Therapeutics is -2.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tenax Therapeutics is -2.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tenax Therapeutics has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Tenax Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    9.27% of the float of Tenax Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Tenax Therapeutics has a short interest ratio ("days to cover") of 14.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Tenax Therapeutics has recently decreased by 0.18%, indicating that investor sentiment is improving.
  • Dividend Yield

    Tenax Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Tenax Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.27% of the float of Tenax Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Tenax Therapeutics has a short interest ratio ("days to cover") of 14.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Tenax Therapeutics has recently decreased by 0.18%, indicating that investor sentiment is improving.
  • Search Interest

    1 people have searched for TENX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tenax Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.14% of the stock of Tenax Therapeutics is held by insiders.

  • Percentage Held by Institutions

    Only 1.67% of the stock of Tenax Therapeutics is held by institutions.

  • Read more about Tenax Therapeutics' insider trading history.
Receive TENX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

TENX Stock News Headlines

TENX Tenax Therapeutics, Inc. - Seeking Alpha
Critical AI announcement set to ignite AI 2.0
While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly taking advantage of a reliable volatility pattern. A veteran trader just revealed how his strategy cuts through the noise—using fast trades, clear rules, and no overnight risk.
Tenax Therapeutics Inc.
Tenax Therapeutics reports Q4 EPS (18c), consensus (43c)
See More Headlines

TENX Stock Analysis - Frequently Asked Questions

Tenax Therapeutics' stock was trading at $6.19 on January 1st, 2025. Since then, TENX stock has decreased by 4.4% and is now trading at $5.9150.

Tenax Therapeutics, Inc. (NASDAQ:TENX) announced its earnings results on Wednesday, May, 14th. The specialty pharmaceutical company reported ($0.28) earnings per share for the quarter, beating analysts' consensus estimates of ($0.48) by $0.20.

Tenax Therapeutics's stock reverse split before market open on Wednesday, January 3rd 2024.The 1-80 reverse split was announced on Wednesday, January 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of TENX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tenax Therapeutics investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Broadcom (AVGO) and Novo Nordisk A/S (NVO).

Company Calendar

Last Earnings
5/14/2025
Today
8/08/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TENX
CIK
34956
Employees
9
Year Founded
1967

Price Target and Rating

High Price Target
$20.00
Low Price Target
$15.00
Potential Upside/Downside
+192.6%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.48)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.60 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-31.51%
Return on Assets
-30.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
40.48
Quick Ratio
40.48

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$26.99 per share
Price / Book
0.22

Miscellaneous

Outstanding Shares
4,150,000
Free Float
4,018,000
Market Cap
$24.82 million
Optionable
Not Optionable
Beta
1.46

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:TENX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners